EV Biologics Company Description

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform.

The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.

The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020.

EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

EV Biologics, Inc.

Country	United States
Founded	2011
Industry	Biotechnology
Sector	Healthcare
CEO	Daniel McKinney

Contact Details

Address: 1621 Central Avenue Cheyenne, Wyoming 82001 United States
Phone	206-734-4738
Website	evbiologics.com

Stock Details

Ticker Symbol	YECO
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US9884971030
SIC Code	3270

Key Executives

Name	Position
Daniel McKinney	Chief Executive Officer
Monte Fisher	Chief Financial Officer